Targeted endoscopic imaging.

Endoscopy has undergone explosive technological growth in recent years, and with the emergence of targeted imaging, its truly transformative power and impact on medicine lies just over the horizon. Today, our ability to see inside the digestive tract with medical endoscopy is headed toward exciting crossroads. The existing paradigm of making diagnostic decisions based on observing structural changes and identifying anatomic landmarks may soon be replaced by visualizing functional properties and imaging molecular expression. In this novel approach, the presence of intracellular and cell surface targets unique to disease are identified and used to predict the likelihood of mucosal transformation and response to therapy. This strategy could result in the development of new methods for early cancer detection, personalized therapy, and chemoprevention. This targeted approach will require further development of molecular probes and endoscopic instruments, and will need support from the US Food and Drug Administration for streamlined regulatory oversight. Overall, this molecular imaging modality promises to significantly broaden the capabilities of the gastroenterologist by providing a new approach to visualize the mucosa of the digestive tract in a manner that has never been seen before.

[1]  R Weissleder,et al.  Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. , 2001, Radiology.

[2]  Ralph Weissleder,et al.  A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. , 2004, Neoplasia.

[3]  Thomas L. Chenevert,et al.  Noninvasive real-time imaging of apoptosis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Noriya Uedo,et al.  DIAGNOSIS OF COLONIC ADENOMAS BY NEW AUTOFLUORESCENCE IMAGING SYSTEM: A PILOT STUDY , 2007 .

[5]  Susan Goodin,et al.  Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases. , 2008, Clinical Therapeutics.

[6]  S. Syngal,et al.  Potential roles of genetic biomarkers in colorectal cancer chemoprevention , 2000, Journal of cellular biochemistry. Supplement.

[7]  Ralph Weissleder,et al.  Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection--study in mice. , 2007, Radiology.

[8]  H. Honda,et al.  Detection of human gastric cancer in resected specimens using a novel infrared fluorescent anti-human carcinoembryonic antigen antibody with an infrared fluorescence endoscope in vitro. , 2001, Endoscopy.

[9]  Thomas D. Wang,et al.  In vivo cancer biomarkers of esophageal neoplasia. , 2008, Cancer biomarkers : section A of Disease markers.

[10]  O. Mäkelä,et al.  Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. , 1984, British Journal of Cancer.

[11]  M. Benito,et al.  Differential Wnt Pathway Gene Expression and E-cadherin Truncation in Sporadic Colorectal Cancers with and without Microsatellite Instability Human Cancer Biology , 2022 .

[12]  M. Pegram,et al.  Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/neu protein and vascular endothelial growth factor. , 2002, Seminars in oncology.

[13]  Ralph Weissleder,et al.  Detection of Invasive Colon Cancer Using a Novel, Targeted, Library-Derived Fluorescent Peptide , 2004, Cancer Research.

[14]  H. Biersack,et al.  FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[16]  Ralph Weissleder,et al.  Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice. , 2002, Gastroenterology.

[17]  M. Hung,et al.  Overexpression of ErbB2 in cancer and ErbB2-targeting strategies , 2000, Oncogene.

[18]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[19]  Christopher H Contag,et al.  Functional imaging of colonic mucosa with a fibered confocal microscope for real-time in vivo pathology. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[20]  R Weissleder,et al.  In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. , 2000, Cancer research.

[21]  J. Pollack,et al.  A gene expression signature of genetic instability in colon cancer. , 2005, Cancer research.

[22]  Robert S. Warren,et al.  A Functional Proteomics Screen of Proteases In Colorectal Carcinoma , 2000, Molecular medicine.

[23]  相良 光久.  Expression of mucin 1(MUC1)in esophageal squamous-cell carcinoma : Its relationship with prognosis , 2001 .

[24]  G. Sledge,et al.  A Phase I-II Study of Combined Blockade of the ErbB Receptor Network with Trastuzumab and Gefitinib in Patients with HER2 (ErbB2)-Overexpressing Metastatic Breast Cancer , 2008, Clinical Cancer Research.

[25]  Christopher H Contag,et al.  Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. , 2008, Nature medicine.

[26]  Patricia L. Blount,et al.  An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. , 1993, Gastroenterology.

[27]  Tetsuo Kimura,et al.  Principle and clinical usefulness of the infrared fluorescence endoscopy , 2004 .

[28]  K. Jaskiewicz,et al.  Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma. , 2004, Neoplasma.

[29]  R. Weinberg,et al.  The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. , 1985, Science.

[30]  H C Hoover,et al.  Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  Carissa A. Sanchez,et al.  Genetic clonal diversity predicts progression to esophageal adenocarcinoma , 2006, Nature Genetics.

[32]  L. Melton,et al.  Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. , 2006, Gastroenterology.

[33]  S. Shackney,et al.  Response to trastuzumab, erlotinib, and bevacizumab, alone and in combination, is correlated with the level of human epidermal growth factor receptor-2 expression in human breast cancer cell lines , 2007, Molecular Cancer Therapeutics.

[34]  Ralph Weissleder,et al.  Protease sensors for bioimaging , 2003, Analytical and bioanalytical chemistry.

[35]  M. Sivak,et al.  Gastrointestinal endoscopy: past and future , 2005, Gut.

[36]  R. Langer,et al.  Significance of HER2 Low-Level Copy Gain in Barrett's Cancer: Implications for Fluorescence In situ Hybridization Testing in Tissues , 2007, Clinical Cancer Research.

[37]  R. Fitzgerald,et al.  Molecular basis of Barrett’s oesophagus and oesophageal adenocarcinoma , 2006, Gut.

[38]  Ralph Weissleder,et al.  Targeted imaging of human endothelial-specific marker in a model of adoptive cell transfer , 2006, Laboratory Investigation.

[39]  Naoki Muguruma,et al.  Basic studies on a labeled anti-mucin antibody detectable by infrared-fluorescence endoscopy , 2002, Journal of Gastroenterology.

[40]  G. Sauter,et al.  Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus , 2007, Modern Pathology.

[41]  N. Koshikawa,et al.  Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model , 2003, Oncogene.

[42]  K. Okita,et al.  Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer , 2003, British Journal of Cancer.

[43]  J. Pawley,et al.  Handbook of Biological Confocal Microscopy , 1990, Springer US.

[44]  A. Polglase,et al.  Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. , 2004, Gastroenterology.

[45]  W. Domschke,et al.  Fluorescence Endoscopy Using a Fluorescein-Labeled Monoclonal Antibody Against Carcinoembryonic Antigen in Patients with Colorectal Carcinoma and Adenoma , 2002, Endoscopy.

[46]  T. Irimura,et al.  Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[47]  C. Heusser,et al.  Immunophotodiagnosis of colon carcinomas in patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen. , 1992, Proceedings of the National Academy of Sciences of the United States of America.